Skip to main content

Full Schedule

Full Schedule

  • Friday, June 16, 2023
  • 8:00 AM – 8:45 AM .
    Session IV: Special Situations in UC

    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine

    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine

  • 8:00 AM – 8:45 AM .
    Session VI: Special Situations in UC
  • 9:00 AM – 10:00 AM .
    Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug

    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine

    Speaker: Florian Rieder, MD – Cleveland Clinic

    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center

  • 10:15 AM – 11:15 AM .
    Non-CME Innovation Theater: A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients
  • 11:30 AM – 12:15 PM .
    Session VI: Optimizing Existing Therapies in the Management of IBD

    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School

  • 12:30 PM – 1:15 PM .
    Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD

    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine

  • 1:30 PM – 2:30 PM .
    Non-CME Innovation Theater: UC Results: a peer-to-peer review of clinical outcomes and long-term safety of a JAK inhibitor for patients with UC
  • 2:45 PM – 3:30 PM .
    Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease

    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale

  • 3:45 PM – 4:30 PM .
    Session IX: Putting your knowledge to the test: Challenging IBD cases

    Panelist: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine

    Panelist: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale